4.5 Article

A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors

Related references

Note: Only part of the references are listed.
Review Oncology

Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy

Michael A. Cannarile et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)

Article Medicine, General & Internal

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

W. D. Tap et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Biochemistry & Molecular Biology

Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma

Bjoern Lamprecht et al.

NATURE MEDICINE (2010)

Article Medicine, General & Internal

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

Christian Steidl et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Hematology

Can FLT3 inhibitors overcome resistance in AML?

Winnie F. Tam et al.

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)

Article Cell Biology

Macrophages define the invasive microenvironment in breast cancer

Jeffrey W. Pollard

JOURNAL OF LEUKOCYTE BIOLOGY (2008)

Review Cell Biology

KIT mutations in GIST

Jonathan A. Fletcher et al.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)

Article Multidisciplinary Sciences

A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells

RB West et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)